Birlinn® DPYD Control Panel Customer Testimonial

The Birlinn® DPYD Control Panel is intended for use as an external quality control to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of genetic variants found in the Dihydropyrimidine Dehydrogenase gene (DPYD). Variants in the DPYD gene may be associated with reduced dihydropyrimidine dehydrogenase (DPD) enzymatic activity, which can result in decreased metabolism of 5-fluorouricil (5-FU), capecitabine, and other fluoropyrimidine-based chemotherapeutic agents. Patients with reduced DPD activity may have an increased risk of severe or life-threatening toxicity following treatment with 5-FU or related fluoropyrimidines.


Product Information:

Birlinn® DPYD Control Panel
Part Number: P112
GTIN: Not available at this time
Kit Contains: 6 tubes x 25µL
Controls/Qty: 2 each of Birlinn DPYD WT, Birlinn DPYD HET, Birlinn DPYD HOM
Storage: Frozen (-25°C to -15°C)

 

ORDER


What Labs Are Saying:

All 18 variants covered WT · HET · HOM replicates Agena platform

“We went live with DPYD testing using Agena’s platform and urgently needed controls. Our Agena representative connected us with MMQCI, and the controls have been working great for us. They covered all 18 mutations included in the testing panel with all expected calls correctly reported. We evaluated replicates of each control type (homozygous, heterozygous, and wild type), and all performed as expected. They have been a great addition to our DPYD testing.”

Reg Davis Lead Molecular Technologist, The Cancer & Hematology Centers, MI